COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 171 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,569 | +4.0% | 13,672 | 0.0% | 0.00% | – |
| Q2 2023 | $293,811 | -7.7% | 13,672 | +3.1% | 0.00% | – |
| Q1 2023 | $318,275 | +3.4% | 13,267 | 0.0% | 0.00% | – |
| Q4 2022 | $307,794 | +43.0% | 13,267 | -1.3% | 0.00% | – |
| Q3 2022 | $215,309 | -11.1% | 13,440 | -1.7% | 0.00% | – |
| Q2 2022 | $242,215 | -17.6% | 13,669 | -5.3% | 0.00% | – |
| Q1 2022 | $293,815 | -14.1% | 14,431 | -21.2% | 0.00% | – |
| Q4 2021 | $342,000 | -8.8% | 18,323 | -3.4% | 0.00% | – |
| Q3 2021 | $375,000 | -22.2% | 18,974 | -6.9% | 0.00% | – |
| Q2 2021 | $482,000 | +2.3% | 20,381 | +2.5% | 0.00% | – |
| Q1 2021 | $471,000 | +11.9% | 19,886 | -5.3% | 0.00% | – |
| Q4 2020 | $421,000 | +0.5% | 21,002 | +4.5% | 0.00% | – |
| Q3 2020 | $419,000 | +18.7% | 20,102 | -2.5% | 0.00% | – |
| Q2 2020 | $353,000 | +5.1% | 20,621 | +0.2% | 0.00% | – |
| Q1 2020 | $336,000 | -17.0% | 20,582 | +4.6% | 0.00% | – |
| Q4 2019 | $405,000 | +68.8% | 19,681 | -6.1% | 0.00% | – |
| Q3 2019 | $240,000 | -13.0% | 20,966 | 0.0% | 0.00% | – |
| Q2 2019 | $276,000 | +67.3% | 20,966 | +92.0% | 0.00% | – |
| Q1 2019 | $165,000 | +1.2% | 10,918 | -1.4% | 0.00% | – |
| Q3 2018 | $163,000 | -69.1% | 11,068 | -50.0% | 0.00% | -100.0% |
| Q2 2018 | $527,000 | +9.6% | 22,127 | +17.5% | 0.00% | 0.0% |
| Q1 2018 | $481,000 | +32.5% | 18,838 | -4.3% | 0.00% | – |
| Q4 2017 | $363,000 | +90.1% | 19,676 | +8.2% | 0.00% | – |
| Q3 2017 | $191,000 | -18.0% | 18,189 | -2.3% | 0.00% | – |
| Q2 2017 | $233,000 | +72.6% | 18,621 | +38.4% | 0.00% | – |
| Q1 2017 | $135,000 | -22.0% | 13,454 | +21.1% | 0.00% | – |
| Q4 2016 | $173,000 | +18.5% | 11,108 | +47.1% | 0.00% | – |
| Q3 2016 | $146,000 | +18.7% | 7,553 | -27.2% | 0.00% | – |
| Q2 2016 | $123,000 | +46.4% | 10,368 | +109.5% | 0.00% | – |
| Q1 2016 | $84,000 | +140.0% | 4,950 | +285.8% | 0.00% | – |
| Q4 2015 | $35,000 | – | 1,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |